Study Name Principal Investigator
(5F9003) A Phase 1b/2 Trial of Hu5F9-G4 in Combination with Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Bryan, Locke
(ALPINE2) Randomized, Double-Blind, Phase 3B Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75 mg Powder and Solvent for Nebulizer Solution / Aztreonam for Inhalation Solution (AZLI) in Pediatric Subjects with Cystic Fibrosis (CF) and New Onset Respiratory Tract Pseudomonas aeruginosa (PA) Infection/Colonization [Aztreonam Lysine for Pseudomonas INfection Eradication 2 (ALPINE 2) Study] McKie, Kathleen
(APOLLO) The APOL1 Long-term Kidney Transplantation Outcomes Network- APOLLO Study Gani, Imran
(BCC015) Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma McDonough, Colleen
(Blue-C Cologuard) Clinical Validation of an Optimized Multi-Target Stool DNA (mtsDNA 2.0) Test, for Colorectal Cancer Screening “Blue-C” Vega, Kenneth
(CONGA) COVID-19 Neurological and Molecular Prospective Cohort Study in Georgia Wang, Xiaoling
(GRI RIC) Chronic Remote Ischemic Conditioning in Vascular Cognitive Impairment: A Dose Escalation Study Bruno, Askiel
(Inspire Adhere) Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry Groves, Michael
(Lung Nodule) A Study to Evaluate a Panel of Blood Biomarkers for Use in Patients Undergoing Evaluation for Lung Cancer, Onc-Ln-04 Islam, Shaheen
(MELODY) A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants Sapp, Erica
(ROP) Randomized, Controlled, Multi-Center Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients with Retinopathy of Prematurity Espinosa, Diego
(RWE Registry) Registry to Evaluate Effectiveness and Safety of the Nanoknife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma Kruse, Edward
4020-01-001: A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an anti-TIM-3 Monoclonal Antibody, in Patients with Advanced Solid Tumors (AMBER) Abdel Karim, Nagla
A phase 2, Multicenter, Open-Label Study to Assess PK/PD of SEG101 (crizanlizumab), with or without Hydroxyurea/Hydroxycarbamide, in Adult Sickle Cell Patients with Vaso-Occlusive Crisis Kutlar, Abdullah
A Phase 3, randomized, placebo-controlled, double-blind clinical study of pembrolizumab (MK-3475) with or without lenvatinib (E7080/MK-7902) to evaluate the safety and efficacy of pembrolizumab and lenvatinib as 1L intervention in a PD-L1 selected population of participants with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) (LEAP-010). Guddati, Achuta
A phase Ib /II trial of pembrolizumab and idelalisib in patients with non-small cell lung cancer (NSCLC) who have failed immune checkpoint inhibitor Hao, Zhonglin
A Phase III, Randomized, Multicenter, Parallel-group, Open- Label Study Evaluating the Efficacy, Safety, and Tolerability of Long-Acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch from an Integrase Inhibitor Single Tablet Regimen in HIV-1 Infected Antiretroviral Therapy Naive Adult Participants Newman, Cheryl
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed By Electroporation With Cellectra™ 5PSP For The Treatment Of HPV-16 And/Or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) Of The Cervix Rungruang, Bunja
A011106; ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: a phase III study Ghamande, Sharad
A011502: A randomized phase III double blinded placebo-controlled trial of aspirin as adjuvant therapy for node-positive, HER2 negative breast cancer: the ABC trial Ghamande, Sharad
A191402CD; TESTING DECISION AIDS TO IMPROVE PROSTATE CANCER DECISIONS FOR MINORITY MEN Ghamande, Sharad
An Objective Tool to Aid Diagnosis of PTSD and Evaluate Treatment outcome Vazdarjanova, Almira
Antibodies in Amyotrophic Lateral Sclerosis Rivner, Michael
Assessment of Immune Cell function of kidney and kidney pancreas transplant recipients. A marker of strength of immunosuppression resulting from maintenance therapy after transplant: A Single Center Experience Gani, Imran
ATHN 10 – Leveraging the ATHNdataset to Document the State of Rare Coagulation Disorders in the United States Kutlar, Abdullah
AVA-CIT-330: A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Active Non-Hematological Cancer Ghamande, Sharad
Breast and Ovarian Cancer in African American Women: Intergenerational Cancer Prevention Vernon, Marlo
CC-16047: A Phase I/II Trial Of Pembrolizumab (MK-3475) And Poly-ICLC (Hiltonol®) In Patients With Metastatic Mismatch Repair-Proficient (MRP) Colon Cancer Nayak-Kapoor, Asha
CDX1140-01: A Phase 1 Study of CDX-1140, a Fully Human Agonist anti-CD40 Monoclonal Antibody, as Monotherapy or in Combination in Patients with Advanced Malignancies Kota, Vamsi
D18-11141: Phase III Randomized Trial of DFP-10917 vs. Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Venetoclax Combination Regimens) or Intensive Reinduction (High and Intermediate Dose Cytarabine Regimens) for Acute Myelogenous Leukemia Patients in Second, Third, or Fourth Salvage Cortes, Jorge
Development of a patient centered primary and secondary prevention intervention for breast and ovarian cancer in African American women Vernon, Marlo
Developmental Gene Discovery Project: Mapping and Identifying New Genes in Uterine and Vaginal Development; Identifying New Genes Causing Birth Defects in Children Layman, Lawrence
Examining Media Frames and Biases in Coverage of Transgendered Athletes Hopkins, Ashley
GCC2020: Repurposing ibrutinib for chemo-immunotherapy in a phase 1b study of ibrutinib with indoximod plus metronomic cyclophosphamide and etoposide for pediatric patients with brain cancer Johnson, Theodore
Genetics of Delayed Puberty/ Genes Important in Puberty, Genetics of Infertility and Medical Illness Layman, Lawrence
Gilead GS-US-200-4334: A Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhibitor GS-6207 in Combination with Other Antiretroviral Agents in People Living with HIV Newman, Cheryl
GS-US-380-4580: A Phase 3b, Multicenter, Open-Label Study to Evaluate Switching From a Regimen of Two Nucleos(t)ide Reverse Transcriptase Inhibitors (NRTI) plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants Newman, Cheryl
LAI116482: A Phase IIb, dose ranging study of oral GSK1265744 in combination with nucleoside reverse transcriptase inhibitors for induction of HIV-1 virologic suppression followed by an evaluation of maintenance of virologic suppression when oral GSK1265744 is combined with oral rilpivirine in HIV-1 infected, antiretroviral therapy naive adult subjects Newman, Cheryl
Mechanisms Regulating Aquaporin 3 Expression in Keratinocytes and the Epidermis Bollag, Wendy
MEI-011: A Two-Stage, Open-Label Followed by Placebo Controlled Phase 2 Study of Pracinostat and Azacitidine in Patients with IPSS-R High and Very High Risk Myelodysplastic Syndromes Previously Untreated with Hypomethylating Agents Pantin, Jeremy
MK-8591A-018: A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate a Switch to Doravirine/Islatravir (DOR/ISL) Once-Daily in Participants With HIV-1 Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Newman, Cheryl
Needs Assessment for Remote Pregnancy and Postpartum Monitoring in Rural Georgia Vernon, Marlo
NMTRC 014: NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO) McDonough, Colleen
NMTRC012: PEDS-PLAN--Pediatric Precision Laboratory Advanced Neuroblastoma Therapy - A study using molecular guided therapy with induction chemotherapy followed by a randomized controlled trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for subjects with newly diagnosed high-risk neuroblastoma McDonough, Colleen
Phase 2 trial of indoximod with chemotherapy and radiation for children with progressive brain tumors or newly diagnosed DIPG Johnson, Theodore
Phase I Study to Determine the Safety and Tolerability of Escalating Doses of Panobinostat (LBH589) in Patients with Sickle Cell Disease Kutlar, Abdullah
POLAR 209035: A Phase IIb, Multicenter, Open-label, Rollover Study Evaluating the Efficacy, Safety and Tolerability of Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months in HIV-1 infected Adults who are Virologically Suppressed and Participated in Study LAI116482 (Pro00025197) Newman, Cheryl
PREEMPT CRC: Prevention of Colorectal Cancer Through Multiomics Blood Testing Vega, Kenneth
RAINBOW study: a randomized, controlled study evaluating the efficacy and safety of RAnibizumab compared with laser therapy for the treatment of Infants Born prematurely With retinopathy of prematurity Bhatia, Jatinder
RBC Deformability in Acute Stroke Singh, Dilip
Retrospective Review of Head and Neck Cancer Patients Byrd, J. Kenneth
Serum measurement of Donor-derived cell-free DNA (dd-cfDNA) for early detection of allograft rejection in Pediatric Kidney Transplants: A Single Center Experience Mirza, Ahmad
TESARO 4010-01-001: A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors Ghamande, Sharad
The association between length and number of deployments on the emotional health and behavior of children and adolescents in military families Londino, Donna
Using a humanized mouse model to predict which potential living donor is immunologically the best match for a prospective living donor kidney transplant recipient. Mulloy, Laura
RESEARCH. INNOVATION. DISCOVERY.